Literature DB >> 25515650

Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.

Xiaoxing Yu1, Grazia Ambrosini, Jason Roszik, Agda Karina Eterovic, Katherine Stempke-Hale, Elisabeth A Seftor, Chandrani Chattopadhyay, Elizabeth Grimm, Richard D Carvajal, Mary J C Hendrix, F Stephen Hodi, Gary K Schwartz, Scott E Woodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25515650     DOI： 10.1111/pcmr.12345

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  19 in total

1.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

Review 2.  KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.

Authors:  Jonas Cicenas; Linas Tamosaitis; Kotryna Kvederaviciute; Ricardas Tarvydas; Gintare Staniute; Karthik Kalyan; Edita Meskinyte-Kausiliene; Vaidotas Stankevicius; Mindaugas Valius
Journal:  Med Oncol       Date:  2017-01-10       Impact factor: 3.064

3.  Short Tandem Repeat (STR) Profiles of Commonly Used Human Ocular Surface Cell Lines.

Authors:  Alison M McDermott; Hasna Baidouri; Ashley M Woodward; Wendy R Kam; Yang Liu; Xiaomin Chen; Jillian F Ziemanski; Kerry Vistisen; Linda D Hazlett; Kelly K Nichols; Pablo Argüeso; David A Sullivan
Journal:  Curr Eye Res       Date:  2018-06-04       Impact factor: 2.424

4.  Obstruction of BRAFV600E transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth.

Authors:  J H Rothman; O Surriga; E de Stanchina; S D Vasudeva; G K Schwartz
Journal:  Cancer Gene Ther       Date:  2017-09-22       Impact factor: 5.987

5.  Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?

Authors:  João Lobo; Carla Pinto; Micaela Freitas; Manuela Pinheiro; Rámon Vizcaino; Esther Oliva; Manuel R Teixeira; Carmen Jerónimo; Carla Bartosch
Journal:  Virchows Arch       Date:  2016-12-03       Impact factor: 4.064

6.  Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma.

Authors:  Yan Zhang; Baoyuan Zhang; Yongyun Li; Yuting Dai; Jiaoyang Li; Donghe Li; Zhizhou Xia; Jianming Zhang; Ping Liu; Ming Chen; Bo Jiao; Ruibao Ren
Journal:  Front Med       Date:  2022-08-23       Impact factor: 9.927

7.  CCR 20th Anniversary Commentary: MAPK/ERK Pathway Inhibition in Melanoma-Kinase Inhibition Redux.

Authors:  Diwakar Davar; John M Kirkwood
Journal:  Clin Cancer Res       Date:  2015-12-15       Impact factor: 12.531

8.  Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.

Authors:  Hanyin Cheng; Mizue Terai; Ken Kageyama; Shinji Ozaki; Peter A McCue; Takami Sato; Andrew E Aplin
Journal:  Cancer Res       Date:  2015-05-07       Impact factor: 12.701

9.  A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.

Authors:  Melody J Xu; Mariana Cooke; David Steinmetz; Giorgos Karakousis; Deeksha Saxena; Edmund Bartlett; Xiaowei Xu; Stephen M Hahn; Jay F Dorsey; Gary D Kao
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line.

Authors:  Parvathi Haridas; Jacqui A McGovern; Abhishek S Kashyap; D L Sean McElwain; Matthew J Simpson
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.